Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.
IPO Year: 2020
Exchange: NASDAQ
Website: frazierlifesciencesacquisition.com
| Date | Price Target | Rating | Analyst |
|---|
8-K - Frazier Lifesciences Acquisition Corp (0001828326) (Filer)
SC 13D - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)